Here are five things to know about the process, according to an Oct. 3 news release from CMS:
- Abbott formally requested the national coverage analysis in a 2023 letter.
- Transcatheter edge-to-edge repair (TEER) is used to treat mitral regurgitation. T-TEER applies similar technology to the treatment of tricuspid valve regurgitation.
- CMS is soliciting public comment, including scientific evidence and peer-reviewed literature, as part of the coverage analysis.
- The public comment period ends Nov. 2.
- CMS expects to complete its analysis by July 2.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
